Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EarkartBOM:544549 -0.81%20 Return-on-Tangible-Equity is 14.78% as of Mar. 2026, which is 37% below its 10-year median of 23.48. GuruFocus rates BOM:544549 with a GF Score™ of 20/100. The stock has 4 warning signs investors should review. Among 756 Medical Devices & Instruments companies, Earkart ranks better than 57.28% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Earkart's annualized net income for the quarter that ended in Mar. 2026 was ₹61.6 Mil. Earkart's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹416.7 Mil. Therefore, Earkart's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 14.78%.
The historical rank and industry rank for Earkart's Return-on-Tangible-Equity or its related term are showing as below:
BOM:544549'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 2.24 Med: 23.48 Max: 42.35
Current: 7.39
During the past 5 years, Earkart's highest Return-on-Tangible-Equity was 42.35%. The lowest was 2.24%. And the median was 23.48%.
BOM:544549's Return-on-Tangible-Equity is ranked better than 57.28% of 756
companies
in the Medical Devices & Instruments industry
Industry Median: 4.855
vs BOM:544549: 7.39
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Earkart Return-on-Tangible-Equity Related Terms
Earkart Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Earkart's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Earkart Return-on-Tangible-Equity Chart
Earkart Annual Data
Trend
Mar22
Mar23
Mar24
Mar25
Mar26
Return-on-Tangible-Equity
2.24
23.48
31.83
42.35
11.84
Earkart Semi-Annual Data
Mar22
Mar23
Mar24
Mar25
Mar26
Return-on-Tangible-Equity
0.00
0.00
0.00
0.00
14.78
BOM:544549 vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, Earkart's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Earkart Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Earkart's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Earkart's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is two times the semi-annual (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 14.78% mean?
Earkart (BOM:544549) has a Return-on-Tangible-Equity of 14.78% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Earkart and its competitors. This is 37% below median its historical median of 23.48. Over the past decade, Earkart's Return-on-Tangible-Equity has ranged from 2.24 to 42.35. According to the industry distribution chart, Earkart ranks #323 out of 756 companies in the Medical Devices & Instruments industry, placing it in the top 42.7%.
Is Earkart's Return-on-Tangible-Equity too high?
Earkart's current Return-on-Tangible-Equity of 14.78% is 37% below median its 10-year median of 23.48. Over the past 10 years, this metric has ranged from a low of 2.24 to a high of 42.35. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.86. Earkart's value of 14.78% is 204.4% above this industry median. Based on the distribution chart, Earkart ranks #323 out of 756 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Earkart has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Earkart's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Earkart ranks #323 out of 756 companies for Return-on-Tangible-Equity. This puts Earkart in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.86. Earkart's value of 14.78% is 204.4% above this benchmark. Historically, Earkart's own Return-on-Tangible-Equity has ranged from 2.24 to 42.35 over the past decade. While the company's 10-year median is 23.48 vs. the industry median of 4.86, Earkart has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.86, based on 756 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Earkart's current Return-on-Tangible-Equity of 14.78% is 204.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Earkart and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Earkart's current Return-on-Tangible-Equity is 14.78%, which is 37% below median its own 10-year median of 23.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Earkart stock overvalued right now?
Earkart (BOM:544549) has a current Return-on-Tangible-Equity of 14.78%. The current Return-on-Tangible-Equity is 14.78%, which is 37% below median its 10-year median of 23.48 and 204.4% above the Medical Devices & Instruments industry median of 4.86. Earkart's overall GF Score™ is 20/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Earkart (BOM:544549), the current Return-on-Tangible-Equity is 14.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Earkart Ltd is a hearing care company based in India that manufactures and distributes modern hearing aids and related accessories at affordable prices. The company also trades in hearing aids and parts from both Indian and foreign brands. Earkart has expanded its product range to include mobility aids like adjustable foldable walkers and therapy kits for children with disabilities. It developed a remote audiometry machine operated by audiologists to facilitate hearing tests remotely, improving access to hearing care services across India. Earkart operates through a wide network of clinics and hearing solution dispensers, blending manufacturing with a customer-focused approach to reach underserved regions.
20GF Score
Get the complete analysis for BOM:544549
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544549 has been successfully added to your 
